Back to top
more

Moderna (MRNA)

(Delayed Data from NSDQ)

$63.96 USD

63.96
24,069,834

+2.16 (3.50%)

Updated Jun 18, 2026 04:00 PM ET

After-Market: $64.03 +0.07 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.00%
2Buy18.14%
3Hold10.18%
4Sell5.72%
5Strong Sell3.11%
S&P50011.49%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (153 out of 247)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Tirthankar Chakraborty headshot

5 Smart Ways to Profit From the Coronavirus Crisis

by Tirthankar Chakraborty

Even though majority of investors are in a state of shock, many know how to profit during uncertain times like these. Here're five ways you can put your money to work amid the coronavirus outbreak.

Sanghamitra Saha headshot

Beat Virus With 2 Sector ETFs & Stocks That Survived 2008 Crisis

by Sanghamitra Saha

These two sectors lost lesser than the broader market during the 2008 financial crisis and may help you to tide over the latest virus crisis.

Kinjel Shah headshot

3 Small Biotechs Provide Coronavirus Drug Development Updates

by Kinjel Shah

Several drug/biotech companies are working on making new antibodies, drugs, and vaccines to prevent and treat COVID-19.

Sreoshi Bera headshot

5 of the Best Coronavirus-Proof Stocks to Invest In Now

by Sreoshi Bera

With coronavirus cases on the rise, lack of labor and supply chain disruption are impacting businesses worldwide. However, certain industries could offer healthy returns on investment.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Buckle, Chipotle Mexican Grill, Co-Diagnostics, Moderna and Regeneron Pharmaceuticals

Tirthankar Chakraborty headshot

5 Stocks to Win Big From Trump's Economic Stimulus

by Tirthankar Chakraborty

Trump floats financial aids to counter the impact of the coronavirus outbreak. Notable stimulus measures include payroll tax cut, aid for wage earners and an emergency funding worth $8.3 billion

Zacks Equity Research

LabCorp (LH) Launches Test to Detect Presence of Coronavirus

by Zacks Equity Research

LabCorp (LH), with an aim to contain the outbreak of coronavirus, launches the LabCorp 2019 Novel Coronavirus (COVID-19), NAA test.

Zacks Equity Research

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Vir Biotechnology and Alnylam Pharmaceuticals

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Moderna, Inovio Pharmaceuticals, Vir Biotechnology and Alnylam Pharmaceuticals

Zacks Equity Research

Regeneron (REGN) Gains from Focus on Coronavirus Treatments

by Zacks Equity Research

Regeneron's (REGN) shares grow year to date owing to focus on developing a treatment for combating the novel coronavirus.

Manaswita Ghosh Dutta headshot

House Okays $8 Billion Funds to Combat COVID-19: 3 Winners

by Manaswita Ghosh Dutta

U.S. lawmakers' deal to find a vaccine for tackling the coronavirus stands to benefit the healthcare industry.